RecallGuide.ca
    Health productsUpdated Jan 3, 2026FibristalOfficial source

    Fibristal recall in Canada: possible link to liver injury

    Share:

    In plain language

    This recall involves the drug Fibristal (ulipristal acetate) sold in Canada. It's being recalled because a safety review found a possible link between its use and a rare but serious liver injury. Stop using the product and follow the return/repair steps in the official notice.

    What to do

    • Stop using the product immediately.
    • Inform your healthcare provider if you have or had liver problems.
    • Be aware that your healthcare provider will do blood tests to assess your liver function.
    • Stop treatment and contact your healthcare provider immediately if you develop symptoms of liver injury.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • Fibristal (ulipristal acetate)

    Why this matters

    Liver injury risk

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    Liver injury risk

    What should consumers do?

    Stop using the product immediately. Inform your healthcare provider if you have or had liver problems. Be aware that your healthcare provider will do blood tests to assess your liver function. Stop treatment and contact your healthcare provider immediately if you develop symptoms of liver injury.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    Yes, there may be a health risk. Liver injury risk

    When was this product recalled?

    This product was recalled on January 11, 2019.

    Is the Fibristal brand affected by this recall?

    Yes, Fibristal products are affected by this recall. This recall involves the drug Fibristal (ulipristal acetate) sold in Canada. It's being recalled because a safety review found a possible link between its use and a rare but serious liver injury. Stop using the product and follow the return/repair steps in the official notice.